[Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
Matsushima
A
A
Enomoto
M
M
Yokoo
Y
Y
Arai
M
M
Kobayashi
T
T
Okuno
F
F
Hirano
Y
Y
Sujita
K
K
Eto
S
S
Takagi
T
T
D000368:Aged; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis*; D006801:Humans; D007124:Immunoenzyme Techniques; D008113:Liver Neoplasms / Q000175:diagnosis*; D008297:Male; D011498:Protein Precursors / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D000509:alpha-Fetoproteins; C008208:acarboxyprothrombin; D011516:Prothrombin